Developer docs
API playgroundTry for free, no card

Search company profiles

NEMA Research

Full company profile

uuid0007em3

Namestring
NEMA Research
Legal namestring
NEMA Research, Inc.
Company typeenum
Private
Founded yearint
1996
Descriptiontext

NEMA Research Inc. is a privately held, physician-led Contract Research Organization (CRO) founded in 1996 and headquartered in Naples, Florida. The company provides full-service Phase I through Phase IV clinical trial services to pharmaceutical companies, medical device companies, research-oriented hospitals, and individual physicians, with therapeutic experience spanning HIT, DIC, oncology, acute and critical care, pain management, and pharmacoeconomic and health outcomes. Its integrated service portfolio covers feasibility, protocol development, clinical monitoring, data management, biostatistics, regulatory affairs, medical writing, project management, medical monitoring, decentralized clinical trial enablement, DSMB services, clinical trial rescue, IRB services (including the first IRB dedicated to nutraceuticals, cosmeceuticals, and dietary supplements), and pharmacoeconomic analysis.

NEMA's technology stack centers on a proprietary pre-feasibility site testing process — combining an online site questionnaire with an on-site meeting and mock protocol run-through — and a tech-enabled Decentralized Clinical Trials platform that supports electronic consent, electronic diaries and assessments, and remote site data monitoring. The firm also maintains a proprietary Key Opinion Leader (KOL) Registry of global thought leaders spanning regulatory, clinical, and research domains, which it draws on across the product lifecycle. The company's medical writing team has produced more than 300 peer-reviewed publications, including in JAMA, and the team has collectively participated in over 400 clinical studies.

NEMA generates revenue through project-based professional services contracts with sponsors; pricing is quote-based and not publicly disclosed. The company employs between 11 and 50 people, operates exclusively in the United States, and has remained privately held since founding with no disclosed outside funding. Its go-to-market is enterprise-focused direct sales, with brand visibility supported by an active publications program and recurring recognition at the Citeline Awards (finalist in 2020, 2021, and 2023).

Short descriptiontext

NEMA Research Inc. is a physician-led, U.S.-based Contract Research Organization founded in 1996 that provides integrated Phase I-IV clinical trial services to pharmaceutical, medical device, and hospital clients, supported by a proprietary KOL Registry and decentralized trial technology.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNaples, United States
HQ citystring
Naples
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial services, contract research organization, clinical monitoring, regulatory affairs, medical writing
Industry5 codes
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAF
Clinical Data Management, Biostatistics & Statistical Programming CROs
SECONDARYHLAGAAAG
Medical Writing & Regulatory Submission Support CROs
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs
SECONDARYHLAGACAC
Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts)
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Contract Research Organization (CRO) Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Research Services
TypeProfessional Services
Description

Full-service CRO providing Phase I-IV clinical trial services including feasibility, protocol development, clinical monitoring, data management, biostatistics, regulatory affairs, medical writing, consulting, and clinical trial rescue services. Revenue is generated through project-based professional services contracts with pharmaceutical and medical device companies.

nemaresearch.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1NEMA Scholars
Description

A unique program designed to encourage young physicians, young scientists, and medical and research scientists to publish their first paper(s) in peer-reviewed journals.

nemaresearch.com
Core offering1 text field

NEMA Research is a fully integrated Contract Research Organization (CRO) providing Phase I-IV clinical trial services for pharmaceutical and medical device companies. Services span feasibility, protocol development, clinical monitoring, data management, biostatistics, regulatory affairs, medical writing, project management, and medical monitoring, delivered through a network of physicians, hospitals, and key opinion leaders.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 300+ peer-reviewed publications in journals including JAMA
+2 more records
Product overview1 text field

NEMA Research is a fully integrated Contract Research Organization (CRO) offering a unified portfolio of Phase I-IV clinical trial services. The core offering consists of Clinical Trial Services Phase I-IV, complemented by specialized sub-products including the KOL Registry (global thought leader network), Decentralized Clinical Trials (tech-enabled remote capabilities), Data Safety Monitoring Services, Clinical Trial Rescue Services, IRB Services, and Health Outcome Pharmacoeconomic Analysis. NEMA Scholars is a separate program supporting young researchers in publishing. The company also employs proprietary research techniques, methodologies, and software as a competitive differentiator. Founded in 1996 and based in Naples, Florida, NEMA differentiates itself through its integrated model and focus on cost-effective, high-quality clinical research solutions.

Product and service2 records
1Clinical Trial Services Phase I-IV
CategoryContract Research Organization (CRO) Services
Description

Comprehensive Phase I through Phase IV clinical trial services covering feasibility, protocol development, clinical monitoring, data management, biostatistics, regulatory affairs, medical writing, project management, and medical monitoring for pharmaceutical and medical device sponsors.

2KOL Registry
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
1Pharmaceutical Companies
Strategic tierCoreTypeOthers
Description

Ongoing partnerships and collaborations providing unique clinical research opportunities for pharmaceutical companies seeking clinical trial services from Phase I to Phase IV. NEMA creates and designs clinical trials as well as places and manages them for pharmaceutical sponsors.

nemaresearch.com
2Medical Device Companies
Strategic tierCoreTypeOthers
Description

Partnerships with medical device companies providing clinical research services and access to NEMA's network of hospitals and physicians for product development clinical trials.

nemaresearch.com
3Research-Oriented Hospitals
Strategic tierCoreTypeStrategic or Co-development Partner
Description

NEMA Research has developed an extensive network of hospitals for conducting clinical trials, providing unique clinical research opportunities and readily available eligible patient databases.

nemaresearch.com
4Individual Physicians/Key Opinion Leaders
Strategic tierCoreTypeStrategic or Co-development Partner
Description

NEMA's network includes research-experienced physicians and Key Opinion Leaders (KOLs) specialized for each study. The KOL Registry includes global thought leaders in regulatory, clinical, and research fields ready to provide insight at any stage of product lifecycle.

nemaresearch.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Specialty early-phase (Phase I/IIa) clinical pharmacology CRO with deep expertise in PK/PD and bioequivalence studies; comparable as a science-focused, mid-sized clinical research services provider.

TypeBroad incumbent
Description

Global full-service CRO formed via the PRA Health Sciences merger, offering end-to-end clinical development and laboratory services across all major therapeutic areas and geographies.

TypeEmerging player
Description

Specialty CRO with strong oncology and rare disease focus plus pharmacovigilance; comparable as a focused, science-led mid-market CRO building a differentiated therapeutic footprint.

TypeDirect peer
Description

Mid-size, US-headquartered full-service CRO operating across Phases I-IV with a physician-led model, similar in positioning to NEMA Research as a focused, science-driven alternative to global mega-CROs.

TypeBroad incumbent
Description

Large CRO combining clinical research with commercial launch services; competes for full-service Phase I-IV work and increasingly for decentralized and real-world evidence capabilities.

TypeBroad incumbent
Description

Major CRO/preclinical services provider with broad Phase I-IV, central lab, and discovery capabilities, often competing for sponsor development programs across multiple service lines.

TypeDirect peer
Description

Mid-tier CRO offering full-service Phase I-IV clinical development, particularly strong in CNS, cardiometabolic, and rare disease — comparable therapeutic breadth and project-based delivery model to NEMA.

TypeBroad incumbent
Description

Full-service CRO with integrated central laboratory, bioanalytical, and early development services acquired from Covance — a direct competitor for end-to-end clinical development mandates.

TypeRegional player
Description

China's largest clinical CRO, offering Phase I-IV services primarily across Asia-Pacific; comparable service model but operating in a different geographic market from US-only NEMA.

TypeBroad incumbent
Description

The largest global CRO with full Phase I-IV capabilities plus technology platforms (eClinical, decentralized trials, real-world evidence) — a key competitor when NEMA pitches against scaled, technology-enabled incumbents.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

NEMA Research

Contract Research Organization (CRO) Servicesnemaresearch.com

NEMA Research Inc. is a physician-led, U.S.-based Contract Research Organization founded in 1996 that provides integrated Phase I-IV clinical trial services to pharmaceutical, medical device, and hospital clients, supported by a proprietary KOL Registry and decentralized trial technology.

What NEMA Research does

NEMA Research Inc. is a privately held, physician-led Contract Research Organization (CRO) founded in 1996 and headquartered in Naples, Florida. The company provides full-service Phase I through Phase IV clinical trial services to pharmaceutical companies, medical device companies, research-oriented hospitals, and individual physicians, with therapeutic experience spanning HIT, DIC, oncology, acute and critical care, pain management, and pharmacoeconomic and health outcomes. Its integrated service portfolio covers feasibility, protocol development, clinical monitoring, data management, biostatistics, regulatory affairs, medical writing, project management, medical monitoring, decentralized clinical trial enablement, DSMB services, clinical trial rescue, IRB services (including the first IRB dedicated to nutraceuticals, cosmeceuticals, and dietary supplements), and pharmacoeconomic analysis.

NEMA's technology stack centers on a proprietary pre-feasibility site testing process — combining an online site questionnaire with an on-site meeting and mock protocol run-through — and a tech-enabled Decentralized Clinical Trials platform that supports electronic consent, electronic diaries and assessments, and remote site data monitoring. The firm also maintains a proprietary Key Opinion Leader (KOL) Registry of global thought leaders spanning regulatory, clinical, and research domains, which it draws on across the product lifecycle. The company's medical writing team has produced more than 300 peer-reviewed publications, including in JAMA, and the team has collectively participated in over 400 clinical studies.

NEMA generates revenue through project-based professional services contracts with sponsors; pricing is quote-based and not publicly disclosed. The company employs between 11 and 50 people, operates exclusively in the United States, and has remained privately held since founding with no disclosed outside funding. Its go-to-market is enterprise-focused direct sales, with brand visibility supported by an active publications program and recurring recognition at the Citeline Awards (finalist in 2020, 2021, and 2023).

NEMA Research firmographics

Firmographics
Name
NEMA Research
Legal name
NEMA Research, Inc.
Website
https://nemaresearch.com
Company type
Private
Founded year
1996
Operating status
Operating
Headcount range
11–50 employees
Short description
NEMA Research Inc. is a physician-led, U.S.-based Contract Research Organization founded in 1996 that provides integrated Phase I-IV clinical trial services to pharmaceutical, medical device, and hospital clients, supported by a proprietary KOL Registry and decentralized trial technology.
Ownership category
akta.pro rank

NEMA Research industry classification

Industry
Product category
Contract Research Organization (CRO) Services
NAICS
Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAF
Clinical Data Management, Biostatistics & Statistical Programming CROs
SECONDARYHLAGAAAG
Medical Writing & Regulatory Submission Support CROs
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs
SECONDARYHLAGACAC
Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts)

Keywords

  • Clinical trial services
  • Contract research organization
  • Clinical monitoring
  • Regulatory affairs
  • Medical writing

Where NEMA Research is headquartered

Location

Headquarters

HQ city
Naples
HQ country
United States
HQ region
North America

Offices1 record

Markets served

NEMA Research business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Clinical Research Services: Full-service CRO providing Phase I-IV clinical trial services including feasibility, protocol development, clinical monitoring, data management, biostatistics, regulatory affairs, medical writing, consulting, and clinical trial rescue services. Revenue is generated through project-based professional services contracts with pharmaceutical and medical device companies.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

NEMA Research product offering

Product offering

Core offering

NEMA Research is a fully integrated Contract Research Organization (CRO) providing Phase I-IV clinical trial services for pharmaceutical and medical device companies. Services span feasibility, protocol development, clinical monitoring, data management, biostatistics, regulatory affairs, medical writing, project management, and medical monitoring, delivered through a network of physicians, hospitals, and key opinion leaders.

Product overview

NEMA Research is a fully integrated Contract Research Organization (CRO) offering a unified portfolio of Phase I-IV clinical trial services. The core offering consists of Clinical Trial Services Phase I-IV, complemented by specialized sub-products including the KOL Registry (global thought leader network), Decentralized Clinical Trials (tech-enabled remote capabilities), Data Safety Monitoring Services, Clinical Trial Rescue Services, IRB Services, and Health Outcome Pharmacoeconomic Analysis. NEMA Scholars is a separate program supporting young researchers in publishing. The company also employs proprietary research techniques, methodologies, and software as a competitive differentiator. Founded in 1996 and based in Naples, Florida, NEMA differentiates itself through its integrated model and focus on cost-effective, high-quality clinical research solutions.

Differentiator

Problem solved

Functional benefit

Brands

  • NEMA Scholars: A unique program designed to encourage young physicians, young scientists, and medical and research scientists to publish their first paper(s) in peer-reviewed journals.

Products and services

  • Clinical Trial Services Phase I-IV Comprehensive Phase I through Phase IV clinical trial services covering feasibility, protocol development, clinical monitoring, data management, biostatistics, regulatory affairs, medical writing, project management, and medical monitoring for pharmaceutical and medical device sponsors.
  • KOL Registry

Quantifiable outcome

  • 300+ peer-reviewed publications in journals including JAMA
  • +2 more outcomes

Companies that use NEMA Research

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles2 records

NEMA Research technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

NEMA Research partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core.

  • Pharmaceutical CompaniescoreOthersOngoing partnerships and collaborations providing unique clinical research opportunities for pharmaceutical companies seeking clinical trial services from Phase I to Phase IV. NEMA creates and designs clinical trials as well as places and manages them for pharmaceutical sponsors.
  • Medical Device CompaniescoreOthersPartnerships with medical device companies providing clinical research services and access to NEMA's network of hospitals and physicians for product development clinical trials.
  • Research-Oriented HospitalscoreStrategic or Co-development PartnerNEMA Research has developed an extensive network of hospitals for conducting clinical trials, providing unique clinical research opportunities and readily available eligible patient databases.
  • Individual Physicians/Key Opinion LeaderscoreStrategic or Co-development PartnerNEMA's network includes research-experienced physicians and Key Opinion Leaders (KOLs) specialized for each study. The KOL Registry includes global thought leaders in regulatory, clinical, and research fields ready to provide insight at any stage of product lifecycle.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

NEMA Research competitors and assessment

Company assessment

Direct peers

  • Celerion: Specialty early-phase (Phase I/IIa) clinical pharmacology CRO with deep expertise in PK/PD and bioequivalence studies; comparable as a science-focused, mid-sized clinical research services provider.
  • Medpace: Mid-size, US-headquartered full-service CRO operating across Phases I-IV with a physician-led model, similar in positioning to NEMA Research as a focused, science-driven alternative to global mega-CROs.
  • Worldwide Clinical Trials: Mid-tier CRO offering full-service Phase I-IV clinical development, particularly strong in CNS, cardiometabolic, and rare disease — comparable therapeutic breadth and project-based delivery model to NEMA.

Broad incumbents

  • ICON plc: Global full-service CRO formed via the PRA Health Sciences merger, offering end-to-end clinical development and laboratory services across all major therapeutic areas and geographies.
  • Syneos Health: Large CRO combining clinical research with commercial launch services; competes for full-service Phase I-IV work and increasingly for decentralized and real-world evidence capabilities.
  • Charles River Laboratories: Major CRO/preclinical services provider with broad Phase I-IV, central lab, and discovery capabilities, often competing for sponsor development programs across multiple service lines.
  • Labcorp Drug Development: Full-service CRO with integrated central laboratory, bioanalytical, and early development services acquired from Covance — a direct competitor for end-to-end clinical development mandates.
  • IQVIA: The largest global CRO with full Phase I-IV capabilities plus technology platforms (eClinical, decentralized trials, real-world evidence) — a key competitor when NEMA pitches against scaled, technology-enabled incumbents.

Emerging players

  • Ergomed plc: Specialty CRO with strong oncology and rare disease focus plus pharmacovigilance; comparable as a focused, science-led mid-market CRO building a differentiated therapeutic footprint.

Regional players

  • Tigermed: China's largest clinical CRO, offering Phase I-IV services primarily across Asia-Pacific; comparable service model but operating in a different geographic market from US-only NEMA.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

NEMA Research social profiles

Digital presence

NEMA Research financial estimates

Financial estimate

Revenue estimate

Valuation estimate

NEMA Research leadership team

Management profile

Number of profiles

Profiles3 records

NEMA Research funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

NEMA Research M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NEMA Research

What does NEMA Research do?

NEMA Research is a fully integrated Contract Research Organization (CRO) providing Phase I-IV clinical trial services for pharmaceutical and medical device companies. Services span feasibility, protocol development, clinical monitoring, data management, biostatistics, regulatory affairs, medical writing, project management, and medical monitoring, delivered through a network of physicians, hospitals, and key opinion leaders.

Is NEMA Research a public or private company?

NEMA Research is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was NEMA Research founded?

NEMA Research was founded in 1996. It employs 11 to 50 people.

Where is NEMA Research based?

NEMA Research is headquartered in Naples, United States, in the North America region.

How does NEMA Research make money?

One revenue line is on record: clinical Research Services.

Who are NEMA Research's main competitors?

Direct peers on record are Celerion, Medpace and Worldwide Clinical Trials. Broad incumbents are ICON plc, Syneos Health, Charles River Laboratories, Labcorp Drug Development and IQVIA. Ergomed plc is listed as an emerging player. Tigermed is listed as a regional player.

Does NEMA Research have an API?

No public API is recorded for NEMA Research.

What industry is NEMA Research in?

NEMA Research's product category is Contract Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAF, Clinical Data Management, Biostatistics & Statistical Programming CROs. Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales